CSK and neoplasm: Furthermore, our observations show that the PGE2 produced also inhibits anti-tumor immunity through the EP2 prostanoid receptor - cAMP - protein kinase A (PKA) - Csk pathway in effector T cells that inhibit T cell activation [11].